SPONSOR
The First People's Hospital of Lianyungang
Total Trials
1
Recruiting
1
Phases
N/A
The First People's Hospital of Lianyungang is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Non-Small-Cell Lung Cancer, Brain Metastases.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First People's Hospital of Lianyungang
How many clinical trials has The First People's Hospital of Lianyungang sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by The First People's Hospital of Lianyungang, of which 1 are actively recruiting participants. These trials cover conditions including Non-Small-Cell Lung Cancer, Brain Metastases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First People's Hospital of Lianyungang research focus on?
The First People's Hospital of Lianyungang clinical trials span Non-Small-Cell Lung Cancer, Brain Metastases. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a The First People's Hospital of Lianyungang clinical trial?
To participate in a The First People's Hospital of Lianyungang trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First People's Hospital of Lianyungang trials with current recruitment status updated daily.
Clinical Trials by The First People's Hospital of Lianyungang
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology